Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Over the past year, we have taken decisive steps to streamline Prenetics and focus our resources on IM8, which has emerged as one of the fastest-growing brands in consumer health.

  80% confidence

• IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations

  80% confidence

• With additional cash resources and zero debt, Prenetics is now better positioned than ever to accelerate IM8's international expansion, invest in innovation, bolster clinical trials, and continue building a generational health and longevity brand. We are confident that this strategic execution and our fortified balance sheet will drive significant long-term value for our shareholders.

  80% confidence

• We are pleased to complete this transaction with Tencent, one of the world's most respected technology companies. This strategic sale provides a significant injection of non-dilutive capital, enhancing our ability to fully execute on IM8's global growth strategy.

  80% confidence

Cited in these Via News reports

• Corporations Refinance $3.2 Billion Debt as Global Maturity Wave Hits Utilities and Satellite Sectors →